Effect of omega3 supplementation on oxidated low density lipoprotein ,interleukin6 and hsCRP in women with polycystic ovary syndrome

Institute for Reproductive Sciences, Research and clinical Center for Infertility0 个研究点目标入组 64 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•females 20-40 years; PCOS diagnostic according to Roterdam criteria and BMI>25; no history about intake of any drug during the last 3 months that may affect the insulin sensitivity or hormonal profile such as: oral contraceptives, glucocorticoids, ovulation induction agents, anti diabetic and anti obesity drugs, estrogenic, antiandrogenic or anti hypertensive medication; not being in any diet in the last 3month; do not have any addiction to tobacco and alcohol; do not taking a Omega-3 supplement in the last 3 months; do not be menopaused; do not use anti-coagulant medicine; do not use anti-depression medication and do not be diabetic and hypothyroidism.
•Exclusion criteria: essentially needs for intake of OCP to treatment; do not will to be in the study; do not obey the protocols of the study and do not digest more than 20% of supplements.

发起方

Institute for Reproductive Sciences, Research and clinical Center for Infertility